FdaApplication
ANDA 205857
Identifiers
- fda_app_no: ANDA205857
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2022-05-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BORTEZOMIB | BORTEZOMIB | 3.5MG/VIAL | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1 product